BMEN 681 Seminar: Bridging the Chasm: Invariant Natural Killer T (iNKT) Cells at the Interface of Innate and Adaptive Immunity

Name: BMEN 681 Seminar: Bridging the Chasm: Invariant Natural Killer T (iNKT) Cells at the Interface of Innate and Adaptive Immunity
Start: 2026-08-27T19:20:00Z
End: 2026-08-27T20:35:00Z
Location: Emerging Technologies Building

When: 2:20 pm
Where: Emerging Technologies Building , College Station
Cost: See listing

Dr. Hammond will discuss her research into the use of invariant natural killer T cells (iNKTs) to restore barrier immunity, immune response, and reinvigorate exhausted cells in patients suffering from chronic infection, inflammation, or certain types of cancer. The talk will include a report on the first patients with hypoxemic respiratory failure/ARDS to be treated with iNKTs in her Phase 2/3 clinical trial in Lviv, Ukraine.

Run by College of Engineering - Biomedical Engineering. Original listing.